Screener
Jade Biosciences JBIO Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Jade Biosciences in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The source filing: Jade Biosciences’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:27 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-212088
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Commitments and contingencies (Note 12) | ||
| Stockholders’ equity: | ||
| Series A non-voting convertible preferred stock, $0.0001 par value; 12,622 shares authorized as of both March 31, 2026 and December 31, 2025; 12,622 shares issued and outstanding as of both March 31, 2026 and December 31, 2025 | 2 | 2 |
| Common stock, $0.0001 par value; 300,000,000 shares authorized as of March 31, 2026 and December 31, 2025, respectively; 49,345,967 and 49,316,287 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | 5 | 5 |
| Additional paid-in capital | 511,554 | 506,771 |
| Accumulated other comprehensive (loss) income | (342) | 129 |
| Accumulated deficit | (214,757) | (174,389) |
| Total stockholders’ equity | 296,462 | 332,518 |
Item 1. Financial Statements.
FAQ
- What is Jade Biosciences's common stock?
- Jade Biosciences (JBIO) reported common stock of $5K in Q1 2026.
- How has Jade Biosciences's common stock changed year-over-year?
- Jade Biosciences's common stock increased by 66.7% year-over-year, from $3K to $5K.
- What is the long-term trend for Jade Biosciences's common stock?
- Over 5 years (2020 to 2025), Jade Biosciences's common stock has grown at a -84.2% compound annual growth rate (CAGR), from $50M to $5K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about Jade Biosciences's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude